These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 22357577)

  • 21. Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure.
    Ambrosy AP; Dunn TP; Heidenreich PA
    Am J Cardiol; 2015 Apr; 115(7):938-41. PubMed ID: 25708860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.
    Broch K; Ueland T; Nymo SH; Kjekshus J; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Cleland JG; Aukrust P; Gullestad L
    Eur J Heart Fail; 2012 Mar; 14(3):268-77. PubMed ID: 22302661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
    Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
    Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial.
    Scholfield M; Schabath MB; Guglin M
    J Card Fail; 2014 Jul; 20(7):476-84. PubMed ID: 24845963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the damage of liver in patients with SARS].
    Guan YJ; Tang XP; Yin CB; Yi ZQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver function tests: what is the risk?
    Titcomb CP
    J Insur Med; 2003; 35(1):26-35. PubMed ID: 14694823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
    Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
    Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
    Sarma S; Mentz RJ; Kwasny MJ; Fought AJ; Huffman M; Subacius H; Nodari S; Konstam M; Swedberg K; Maggioni AP; Zannad F; Bonow RO; Gheorghiade M;
    Eur J Heart Fail; 2013 Feb; 15(2):194-202. PubMed ID: 23059198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.
    Biegus J; Zymliński R; Szachniewicz J; Siwołowski P; Pawluś A; Banasiak W; Jankowska EA; Ponikowski P
    Kardiol Pol; 2011; 69(10):997-1005. PubMed ID: 22006596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
    Hsieh MH; Ho CK; Hou NJ; Hsieh MY; Lin WY; Yang JF; Chiu CC; Huang JF; Chang NC; Wang CL; Dai CY; Chuang WL; Yu ML
    Int J Obes (Lond); 2009 Nov; 33(11):1309-17. PubMed ID: 19752878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry.
    Ambrosy AP; Gheorghiade M; Bubenek S; Vinereanu D; Vaduganathan M; Macarie C; Chioncel O;
    Eur Heart J Acute Cardiovasc Care; 2013 Jun; 2(2):99-108. PubMed ID: 24222818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac hepatopathy before and after heart transplantation.
    Dichtl W; Vogel W; Dunst KM; Grander W; Alber HF; Frick M; Antretter H; Laufer G; Pachinger O; Pölzl G
    Transpl Int; 2005 Jun; 18(6):697-702. PubMed ID: 15910296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure.
    Jackson CE; Myles RC; Tsorlalis IK; Dalzell JR; Spooner RJ; Rodgers JR; Bezlyak V; Greenlaw N; Ford I; Cobbe SM; Petrie MC; McMurray JJ
    Eur J Heart Fail; 2012 Apr; 14(4):377-86. PubMed ID: 22334727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent occurrence of high gamma-glutamyl transferase and alanine amino transferase among Nigerian patients with type 2 diabetes.
    Balogun WO; Adeleye JO; Akinlade KS; Adedapo KS; Kuti M
    Afr J Med Med Sci; 2008 Jun; 37(2):177-83. PubMed ID: 18939403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial.
    Mentz RJ; Schmidt PH; Kwasny MJ; Ambrosy AP; O'Connor CM; Konstam MA; Zannad F; Maggioni AP; Swedberg K; Gheorghiade M
    J Card Fail; 2012 Jul; 18(7):515-23. PubMed ID: 22748484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure.
    Vaduganathan M; Marti CN; Mentz RJ; Greene SJ; Ambrosy AP; Subacius HP; Fonarow GC; Chioncel O; Bazari H; Maggioni AP; Zannad F; Konstam MA; Sato N; Gheorghiade M; Butler J;
    Am J Cardiol; 2016 Apr; 117(7):1144-50. PubMed ID: 26851146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study.
    Miura M; Shiba N; Nochioka K; Takada T; Takahashi J; Kohno H; Shimokawa H;
    Eur J Heart Fail; 2012 Apr; 14(4):367-76. PubMed ID: 22298637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.